Understanding Scleroderma and Raynaud's

Scleroderma vs. Raynaud's

Full treatment for scleroderma remains elusive, but ACE inhibitors, commonly used with heart patients, have been successful in treating people with both scleroderma and kidney problems, a combination that ten years ago was considered lethal. For some patients, treatment consists of the immunosuppressant azothioprin.

Scleroderma: Key Facts

  • A chronic autoimmune disease affecting the connective tissue.
  • Symptoms affect the skin and can affect internal organs (lungs, heart, kidneys).
  • The disease ranges from mild to life threatening.
  • It can cause fatigue, weight loss, dry mouth and eyes.
  • Swallowing can become problematic
  • Affected joints and bones impact on mobility.
  • It is not contagious, cancerous or malignant.

Raynaud's: Key Facts

  • A condition that interrupts blood supply to the extremities.
  • Symptoms affect fingers, toes, ears and nose.
  • Secondary Raynaud's is associated with scleroderma.
  • It can be triggered by touching cold objects,
  • Anxiety, stress and smoking can lead to the onset.
  • Women are affected nine times more often than men
  • It can be hereditary.

More to Explore